首页> 美国卫生研究院文献>OncoTargets and therapy >Radiotherapy of Pulmonary Hepatoid Adenocarcinoma with Intrahepatic Hemangioma: A Case Report
【2h】

Radiotherapy of Pulmonary Hepatoid Adenocarcinoma with Intrahepatic Hemangioma: A Case Report

机译:具有肝内血管瘤的肺肝腺癌的放射疗法:案例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatoid adenocarcinoma is defined as an extrahepatic adenocarcinoma with hepatocyte differentiation, characterized by high malignancy and poor prognosis. Herein, we report the diagnosis, treatment and survival of a patient with pulmonary hepatoid adenocarcinoma who had received radiotherapy only. The patient was a 41-year-old man diagnosed with local advanced lung cancer (T3N3M0, stage IIIC). He had an intrahepatic hemangioma and abnormal serum liver enzymes. The patient developed intermittent fever with increased white blood cells and granulocytes during radiotherapy. After 38Gy/19 fractions of radiotherapy, the blood routine results returned to normal levels. After 50Gy/25 fractions of radiotherapy, the patient’s tumor was significantly shrank in imaging. Although the patient refused to receive any treatment after radiotherapy and died 12 months after diagnosis, the data presented here represent a valuable resource for understanding the survival benefits of pulmonary hepatoid adenocarcinoma patients treated with radiotherapy alone.
机译:肝腺癌被定义为具有肝细胞分化的脱胸腺腺癌,其特征在于恶性肿瘤率高,预后差。在此,我们报告了患者患者的肺肝腺癌仅诊断,治疗和存活仅接受放疗的肺肝腺癌。患者是一名41岁的人被诊断出患有局部晚期肺癌(T3N3M0,II阶段)。他有肝内血管瘤和异常的血清肝酶。患者在放射治疗过程中发育了增加的白细胞和颗粒细胞的间歇性。在38Gy / 19分数的放射疗法后,血液常规结果恢复到正常水平。在50Gy / 25分数的放射疗法后,患者的肿瘤在成像中显着缩小。虽然患者在放疗后拒绝接受任何治疗并在诊断后12个月死亡,但这里提出的数据代表了理解单独用放射治疗治疗肺肝腺癌患者的生存益处的宝贵资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号